Skip to main content

Unlearn

By Jessica Hagen | 05:40 pm | April 01, 2025
Trace will use Unlearn's digital twin generator for ALS to create digital twins of clinical trial participants to advance ALS research. 
By Jessica Hagen | 01:34 pm | February 08, 2024
The California-based company will put the funds toward its workforce, growing its data and further investing in R&D initiatives and engineering capabilities.
By Emily Olsen | 03:22 pm | April 19, 2022
Also: RPM company Blue Spark Technologies brought in $40 million in IP-backed debt financing, and Click Therapeutics secured a $15 million loan.
By Mallory Hackett | 01:13 pm | November 05, 2020
With the creation of digital twins in studies, Unlearn generates an intelligent control arm that can reduce the sample size and decrease the number of participants given the placebo.